[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-369181-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-369181-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","a-computational-recognition-analysis-of-promising-prognostic-biomarkers-in-breast-colon-and-lung-cancer-patients-article","A Computational Recognition Analysis of Promising Prognostic Biomarkers in Breast, Colon and Lung Cancer Patients - Article","","Breast, colon, and lung carcinomas are aggressive cancers often accompanied by poor relapse-free survival (RFS), progression-free survival (PF), and unfavorable hazard ratios (HRs) despite extensive therapy. Identifying gene expression signatures linked to RFS/PF and HR is therefore crucial for predicting treatment effectiveness. RNA-binding proteins (RBPs) regulate RNA transcription, maturation, and post-translational control, yet their cancer roles remain incompletely defined. Computational bioinformatics was used to classify RBP functions and correlations across solid cancers.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/a-computational-recognition-analysis-of-promising-prognostic-biomarkers-in-breast-colon-and-lung-cancer-patients-article/369181/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/a-computational-recognition-analysis-of-promising-prognostic-biomarkers-in-breast-colon-and-lung-cancer-patients-article/369181.png","ImageObject",300,407,{"name":42,"@type":43},"Aria","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-25","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What problem does the study address in breast, colon, and lung cancer patients?","Question",{"text":63,"@type":64},"It targets the poor RFS and PF and unfavorable hazard ratios seen despite treatment, and the need to find gene expression signatures that predict prognosis and treatment efficiency.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Why are RNA-binding proteins (RBPs) central to this research?",{"text":68,"@type":64},"RBPs control RNA metabolism through transcription, maturation, and post-transcriptional regulation. Their involvement in cancer is not fully understood, motivating computational analysis of their prognostic relationships.",{"name":70,"@type":61,"acceptedAnswer":71},"What was the main computational approach used to find prognostic biomarkers?",{"text":72,"@type":64},"The study performed computational bioinformatics to classify RBP functions and correlations, used intersection and cluster analysis, and applied hierarchical clustering to define union RBPs tied to RFS/PF and HR patterns.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},369181,1790220148,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":127,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","Article  \nA Computational Recognition Analysis of Promising Prognostic Biomarkers in Breast, Colon and Lung Cancer Patients  \nTala Bakheet 1, Nada Al-Mutairi 1, Mosaab Doubi 1, Wijdan Al-Ahmadi 1, Khaled Alhosaini 2,3 and Fahad Al-Zoghaibi 1, *  \nAcademic Editor: Josiah Ochieng  \nReceived: 1 December 2024  \nRevised: 16 January 2025  \nAccepted: 20 January 2025  \nPublished: 25 January 2025  \nCitation: Bakheet, T.; Al-Mutairi, N.; Doubi, M.; Al-Ahmadi, W.; Alhosaini, K.; Al-Zoghaibi, F. A Computational Recognition Analysis of Promising Prognostic Biomarkers in Breast, Colon and Lung Cancer Patients. Int. J. Mol. Sci. 2025, 26, 1017. [https://](https://)[ ](https://)[doi.org/10.3390/ijms26031017](doi.org/10.3390/ijms26031017)  \n[Copyright:](Copyright:) © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Molecular BioMedicine Program, King Faisal Specialist Hospital & Research Centre, Riyadh 11211, Saudi Arabia; [tala@kfshrc.edu.sa](tala@kfshrc.edu.sa) (T.B.); [nalmutairi28@kfshrc.edu.sa](nalmutairi28@kfshrc.edu.sa) (N.A.-M.); [mdoubi02@kfshrc.edu.sa](mdoubi02@kfshrc.edu.sa) (M.D.); [walahmadi@kfshrc.edu.sa](walahmadi@kfshrc.edu.sa) (W.A.-A.)  \n2 Department of Pharmacology & Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia; [kalhosaini@ksu.edu.sa](kalhosaini@ksu.edu.sa)  \n3 Department of Molecular and Cell Biology, University of Leicester, Leicester LE1 7RH, UK  \n* Correspondence: [zoghaibi@kfshrc.edu.sa](zoghaibi@kfshrc.edu.sa); Tel.: +966-11-442-7876 (ext. 36502); Fax: +966-11-442-4182  \nAbstract: Breast, colon, and lung carcinomas are classified as aggressive tumors with poor relapse-free survival (RFS), progression-free survival (PF), and poor hazard ratios (HRs) despite extensive therapy. Therefore, it is essential to identify a gene expression signature that correlates with RFS/PF and HR status in order to predict treatment efficiency. RNAbinding proteins (RBPs) play critical roles in RNA metabolism, including RNA transcription, maturation, and post-translational regulation. However, their involvement in cancer isnot yet fully understood. In this study, we used computational bioinformatics to classify the functions and correlations of RBPs in solid cancers. We aimed to identify molecular biomarkers that could help predict disease prognosis and improve the therapeutic efficiency in treated patients. Intersection analysis summarized more than 1659 RBPs across three recently updated RNA databases. Bioinformatics analysis showed that 58 RBPs were common in breast, colon, and lung cancers, with HR values \u003C 1 and >1 and a significant Q-value \u003C 0.0001 . RBP gene clusters were identified based on RFS/PF, HR, p-value, and fold induction. To define union RBPs, common genes were subjected to hierarchical clustering and were classified into two groups. Poor survival was associated with high genes expression, including CDKN2A, MEX3A, RPL39L, VARS, GSPT1, SNRPE, SSR1, and TIA1 in breast and colon cancer but not with lung cancer; and poor survival was associated with low genes expression, including PPARGC1B, EIF4E3, and SMAD9 in breast, colon, and lung cancer. This study highlights the significant contribution of PPARGC1B, EIF4E3, and SMAD9 out of 11 RBP genes as prognostic predictors in patients with breast, colon, and lung cancers and their potential application in personalized therapy.  \nKeywords: prognostic biomarkers; RFS; PF; HR; breast cancer; colon cancer; lung cancer; prognostic predictors  \n1. Introduction  \nCancer is one of the deadliest illnesses in the world. According to a World Health Organization (WHO) report in 2020, 10 million new cancers are diagnosed globally each year, and this number is expected to increase to 20 ","cbCaiiCHVvOxWs1M","https://ap.wps.com/l/cbCaiiCHVvOxWs1M","pdf",2295382,"English","# Abstract\n# 1. Introduction\n## Cancer burden and survival challenges\n## Gene expression signatures and precision medicine\n## Role of RNA-binding proteins (RBPs)","[{\"question\":\"What problem does the study address in breast, colon, and lung cancer patients?\",\"answer\":\"It targets the poor RFS and PF and unfavorable hazard ratios seen despite treatment, and the need to find gene expression signatures that predict prognosis and treatment efficiency.\"},{\"question\":\"Why are RNA-binding proteins (RBPs) central to this research?\",\"answer\":\"RBPs control RNA metabolism through transcription, maturation, and post-transcriptional regulation. Their involvement in cancer is not fully understood, motivating computational analysis of their prognostic relationships.\"},{\"question\":\"What was the main computational approach used to find prognostic biomarkers?\",\"answer\":\"The study performed computational bioinformatics to classify RBP functions and correlations, used intersection and cluster analysis, and applied hierarchical clustering to define union RBPs tied to RFS/PF and HR patterns.\"}]","A Computational Recognition Analysis of Promising Prognostic Biomarkers in Breast, Colon and Lung Cancer Patients - Article | PDF",1790181253,48,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/df97b520187264c29763c6fadc066e60.webp",983,1390,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8c17473502a9babcc05872db371a25c6.webp",982,1388,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c53d1e1417f93be8c1b78ab94f0b8bf0.webp",981,1387,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c70f599fb9c85d7fe0f60216af3e86d0.webp",980,1385]